- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/26 - Glucagons
Patent holdings for IPC class A61K 38/26
Total number of patents in this class: 2218
10-year publication summary
|
166
|
167
|
238
|
196
|
247
|
251
|
236
|
239
|
180
|
73
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novo Nordisk A/S | 2324 |
176 |
| Hanmi Pharm. Co., Ltd. | 546 |
108 |
| Zealand Pharma A/S | 211 |
86 |
| Eli Lilly and Company | 3645 |
75 |
| Sanofi-Aventis Deutschland GmbH | 2738 |
57 |
| Sanofi | 3836 |
55 |
| MannKind Corporation | 531 |
50 |
| Rani Therapeutics, LLC | 184 |
48 |
| Intarcia Therapeutics, Inc. | 114 |
37 |
| Xeris Pharmaceuticals, Inc. | 94 |
36 |
| Adocia | 143 |
30 |
| Shire-nps Pharmaceuticals, Inc. | 43 |
28 |
| Indiana University Research and Technology Corporation | 808 |
26 |
| Boehringer Ingelheim International GmbH | 4629 |
22 |
| MedImmune Limited | 627 |
21 |
| Amgen Inc. | 3779 |
18 |
| Merck Sharp & Dohme LLC | 3689 |
18 |
| Janssen Pharmaceutica N.V. | 3839 |
17 |
| The Trustees of the University of Pennsylvania | 4122 |
16 |
| Nano Precision Medical, Inc. | 34 |
16 |
| Other owners | 1278 |